Synergistic Interaction of Histone Deacetylase 6- and MEK-Inhibitors in Castration-Resistant Prostate Cancer Cells
In spite of new knowledge on prostate cancer molecular landscape, this has been only partially translated to the therapeutic setting. The activation of Ras/Mitogen-activated protein kinase (MAPK) signaling plays an important role in progression of prostate cancer in which deregulation of histone dea...
Main Authors: | Cristina Corno, Noemi Arrighetti, Emilio Ciusani, Elisabetta Corna, Nives Carenini, Nadia Zaffaroni, Laura Gatti, Paola Perego |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.00610/full |
Similar Items
-
Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models
by: Keisuke Enomoto, et al.
Published: (2021-02-01) -
Phase I trial of the MEK inhibitor selumetinib in combination with thoracic radiotherapy in non-small cell lung cancer
by: K. Haslett, et al.
Published: (2021-05-01) -
Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells
by: Eszter Molnár, et al.
Published: (2018-05-01) -
Horizontal Combination of MEK and PI3K/mTOR Inhibition in BRAF Mutant Tumor Cells with or without Concomitant PI3K Pathway Mutations
by: Dominika Rittler, et al.
Published: (2020-10-01) -
Attenuation of everolimus-induced cytotoxicity by a protective autophagic pathway involving ERK activation in renal cell carcinoma cells
by: Zeng YZ, et al.
Published: (2018-04-01)